Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Breast Neoplasms | 114 | 2024 | 20982 | 4.000 |
Why?
|
Breast | 28 | 2024 | 1964 | 3.730 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 19 | 2023 | 926 | 2.930 |
Why?
|
Breast Diseases | 18 | 2021 | 443 | 2.040 |
Why?
|
Receptors, Estrogen | 37 | 2023 | 2208 | 1.830 |
Why?
|
Receptors, Progesterone | 28 | 2021 | 1129 | 1.550 |
Why?
|
Receptor, erbB-2 | 25 | 2023 | 2553 | 1.330 |
Why?
|
Keratins | 6 | 2015 | 498 | 1.140 |
Why?
|
Carcinoma in Situ | 8 | 2022 | 791 | 1.110 |
Why?
|
Carcinoma, Lobular | 8 | 2022 | 480 | 1.090 |
Why?
|
Carcinoma, Ductal, Breast | 11 | 2023 | 1084 | 0.890 |
Why?
|
Hyperplasia | 7 | 2022 | 1150 | 0.830 |
Why?
|
Reproductive History | 5 | 2021 | 210 | 0.790 |
Why?
|
Precancerous Conditions | 9 | 2017 | 982 | 0.780 |
Why?
|
Immunohistochemistry | 20 | 2021 | 11067 | 0.750 |
Why?
|
Estrogen Receptor alpha | 4 | 2021 | 582 | 0.740 |
Why?
|
Carcinoma, Papillary | 5 | 2022 | 785 | 0.700 |
Why?
|
Uveal Neoplasms | 4 | 2024 | 341 | 0.680 |
Why?
|
Tissue Array Analysis | 13 | 2021 | 550 | 0.580 |
Why?
|
BRCA1 Protein | 2 | 2021 | 1149 | 0.550 |
Why?
|
BRCA2 Protein | 1 | 2021 | 797 | 0.540 |
Why?
|
Epithelium | 4 | 2021 | 1603 | 0.540 |
Why?
|
Receptors, Androgen | 6 | 2019 | 1077 | 0.510 |
Why?
|
Neoplasm Recurrence, Local | 14 | 2023 | 9278 | 0.500 |
Why?
|
Biopsy | 14 | 2024 | 6781 | 0.490 |
Why?
|
Female | 131 | 2024 | 392544 | 0.480 |
Why?
|
Biopsy, Needle | 4 | 2009 | 1624 | 0.450 |
Why?
|
Nomograms | 1 | 2015 | 230 | 0.430 |
Why?
|
Genes, BRCA1 | 4 | 2010 | 754 | 0.400 |
Why?
|
Neoplasm Invasiveness | 13 | 2016 | 3590 | 0.380 |
Why?
|
Neoplasms, Second Primary | 3 | 2024 | 1052 | 0.380 |
Why?
|
Molecular Typing | 1 | 2011 | 116 | 0.370 |
Why?
|
Humans | 151 | 2024 | 761208 | 0.360 |
Why?
|
Muscle Cells | 2 | 2009 | 195 | 0.360 |
Why?
|
Mammography | 11 | 2020 | 2430 | 0.360 |
Why?
|
Adult | 87 | 2024 | 221119 | 0.360 |
Why?
|
Mammary Glands, Human | 4 | 2021 | 202 | 0.360 |
Why?
|
Epithelial Cells | 5 | 2010 | 3671 | 0.350 |
Why?
|
Parity | 5 | 2021 | 929 | 0.340 |
Why?
|
Case-Control Studies | 22 | 2021 | 22174 | 0.320 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2017 | 2820 | 0.300 |
Why?
|
Risk Factors | 41 | 2024 | 74239 | 0.290 |
Why?
|
Middle Aged | 75 | 2024 | 220853 | 0.280 |
Why?
|
Mucocele | 2 | 2022 | 51 | 0.280 |
Why?
|
Breast Cyst | 1 | 2006 | 8 | 0.270 |
Why?
|
Agaricales | 1 | 2006 | 30 | 0.270 |
Why?
|
Papilloma | 3 | 2015 | 140 | 0.260 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2010 | 698 | 0.260 |
Why?
|
Vaginal Smears | 2 | 2001 | 499 | 0.250 |
Why?
|
Prognosis | 20 | 2023 | 29687 | 0.250 |
Why?
|
Neoadjuvant Therapy | 3 | 2020 | 2827 | 0.240 |
Why?
|
Diagnosis, Differential | 4 | 2017 | 12976 | 0.240 |
Why?
|
Uterine Cervical Dysplasia | 2 | 2001 | 384 | 0.240 |
Why?
|
Prospective Studies | 26 | 2024 | 54435 | 0.240 |
Why?
|
Pathology | 1 | 2008 | 269 | 0.240 |
Why?
|
Mutation | 8 | 2023 | 30002 | 0.240 |
Why?
|
Integrins | 5 | 2001 | 835 | 0.240 |
Why?
|
Immunophenotyping | 4 | 2017 | 1867 | 0.230 |
Why?
|
Melanoma | 4 | 2024 | 5694 | 0.230 |
Why?
|
Laboratories | 1 | 2008 | 462 | 0.230 |
Why?
|
Nurses | 11 | 2020 | 2477 | 0.230 |
Why?
|
Gene Expression Profiling | 7 | 2019 | 9416 | 0.220 |
Why?
|
Cadherins | 4 | 2022 | 902 | 0.210 |
Why?
|
Polysaccharides | 2 | 2007 | 1014 | 0.210 |
Why?
|
Fibrocystic Breast Disease | 2 | 2013 | 103 | 0.200 |
Why?
|
Medical Records | 1 | 2008 | 1409 | 0.200 |
Why?
|
Sclerosis | 2 | 2015 | 210 | 0.200 |
Why?
|
Cohort Studies | 19 | 2021 | 41496 | 0.180 |
Why?
|
Prolactin | 1 | 2023 | 625 | 0.180 |
Why?
|
Neoplasm Staging | 12 | 2016 | 11119 | 0.180 |
Why?
|
Alcohol Drinking | 5 | 2020 | 4027 | 0.180 |
Why?
|
Gene Transfer Techniques | 6 | 2005 | 1201 | 0.180 |
Why?
|
Young Adult | 16 | 2024 | 59221 | 0.180 |
Why?
|
Odds Ratio | 8 | 2015 | 9652 | 0.170 |
Why?
|
Diet, Vegetarian | 1 | 2021 | 180 | 0.170 |
Why?
|
Doxorubicin | 1 | 2006 | 2224 | 0.170 |
Why?
|
Osteoprotegerin | 1 | 2020 | 177 | 0.160 |
Why?
|
Specimen Handling | 1 | 2024 | 702 | 0.160 |
Why?
|
Postmenopause | 6 | 2015 | 2514 | 0.160 |
Why?
|
Mastectomy, Segmental | 5 | 2022 | 955 | 0.160 |
Why?
|
Erythrocyte Membrane | 1 | 2020 | 438 | 0.160 |
Why?
|
Aged | 33 | 2024 | 169288 | 0.160 |
Why?
|
Gene Expression | 6 | 2015 | 7571 | 0.150 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2022 | 517 | 0.150 |
Why?
|
Recombinant Fusion Proteins | 2 | 2023 | 3726 | 0.150 |
Why?
|
Genetic Vectors | 5 | 2001 | 3388 | 0.150 |
Why?
|
Stromal Cells | 4 | 2021 | 1329 | 0.140 |
Why?
|
Age Factors | 6 | 2021 | 18384 | 0.140 |
Why?
|
Adolescent | 19 | 2021 | 88298 | 0.140 |
Why?
|
Aged, 80 and over | 17 | 2024 | 58952 | 0.140 |
Why?
|
Keratin-5 | 3 | 2011 | 45 | 0.140 |
Why?
|
Cervix Uteri | 1 | 2001 | 570 | 0.140 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2020 | 8998 | 0.140 |
Why?
|
Body Height | 2 | 2020 | 1566 | 0.140 |
Why?
|
Body Size | 2 | 2021 | 463 | 0.140 |
Why?
|
Pathology, Surgical | 1 | 2017 | 151 | 0.130 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2001 | 2019 | 0.130 |
Why?
|
Surgery, Computer-Assisted | 1 | 2004 | 1003 | 0.130 |
Why?
|
Menarche | 2 | 2021 | 532 | 0.130 |
Why?
|
Phenotype | 7 | 2020 | 16575 | 0.120 |
Why?
|
Ki-67 Antigen | 1 | 2017 | 628 | 0.120 |
Why?
|
Holistic Nursing | 1 | 2014 | 3 | 0.120 |
Why?
|
Risk | 6 | 2021 | 9616 | 0.120 |
Why?
|
Keratin-6 | 2 | 2011 | 17 | 0.120 |
Why?
|
Neoplasm, Residual | 1 | 2020 | 1008 | 0.120 |
Why?
|
Follow-Up Studies | 12 | 2024 | 39126 | 0.120 |
Why?
|
Immunoconjugates | 1 | 2022 | 963 | 0.110 |
Why?
|
Metaplasia | 1 | 2015 | 324 | 0.110 |
Why?
|
Genomics | 4 | 2023 | 5828 | 0.110 |
Why?
|
Apoptosis | 2 | 2007 | 9477 | 0.110 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2020 | 937 | 0.110 |
Why?
|
Reproducibility of Results | 8 | 2021 | 20119 | 0.110 |
Why?
|
Proportional Hazards Models | 10 | 2021 | 12474 | 0.110 |
Why?
|
Tumor Burden | 3 | 2016 | 1892 | 0.110 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2012 | 1933 | 0.110 |
Why?
|
Androgens | 1 | 2020 | 1283 | 0.110 |
Why?
|
Logistic Models | 6 | 2016 | 13249 | 0.100 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 2 | 2012 | 415 | 0.100 |
Why?
|
Predictive Value of Tests | 6 | 2021 | 15308 | 0.100 |
Why?
|
Polylysine | 3 | 2001 | 131 | 0.100 |
Why?
|
HLA-A Antigens | 2 | 2023 | 223 | 0.100 |
Why?
|
Fatty Acids | 1 | 2020 | 1807 | 0.100 |
Why?
|
Tumor Cells, Cultured | 6 | 2012 | 6124 | 0.100 |
Why?
|
Deoxyadenine Nucleotides | 1 | 2011 | 14 | 0.100 |
Why?
|
Crotalid Venoms | 2 | 2001 | 28 | 0.100 |
Why?
|
Genetic Predisposition to Disease | 3 | 2019 | 17897 | 0.100 |
Why?
|
Dinucleoside Phosphates | 1 | 2011 | 68 | 0.100 |
Why?
|
Medical Oncology | 1 | 2023 | 2320 | 0.100 |
Why?
|
Inflammation Mediators | 1 | 2020 | 1885 | 0.100 |
Why?
|
Deoxyguanosine | 1 | 2011 | 92 | 0.090 |
Why?
|
DNA Adducts | 1 | 2011 | 94 | 0.090 |
Why?
|
Antineoplastic Agents | 3 | 2011 | 13632 | 0.090 |
Why?
|
In Situ Hybridization | 1 | 2015 | 1900 | 0.090 |
Why?
|
Oligopeptides | 4 | 2012 | 1179 | 0.090 |
Why?
|
Health Surveys | 2 | 2018 | 4037 | 0.090 |
Why?
|
Adiposity | 1 | 2020 | 1879 | 0.090 |
Why?
|
Receptors, Cell Surface | 2 | 2015 | 2802 | 0.090 |
Why?
|
Interinstitutional Relations | 1 | 2012 | 236 | 0.090 |
Why?
|
Vitamin D | 2 | 2016 | 3301 | 0.090 |
Why?
|
Breast Feeding | 1 | 2019 | 1356 | 0.090 |
Why?
|
Aspirin | 3 | 2012 | 3129 | 0.090 |
Why?
|
Risk Assessment | 10 | 2021 | 24021 | 0.090 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2023 | 11733 | 0.090 |
Why?
|
Organoplatinum Compounds | 1 | 2011 | 407 | 0.090 |
Why?
|
Cell Nucleus | 2 | 2011 | 2881 | 0.080 |
Why?
|
Sexual Behavior | 1 | 2020 | 2189 | 0.080 |
Why?
|
Organ Transplantation | 1 | 2000 | 1165 | 0.080 |
Why?
|
Carcinoma, Ductal | 1 | 2010 | 97 | 0.080 |
Why?
|
Incidence | 9 | 2024 | 21365 | 0.080 |
Why?
|
Testosterone | 1 | 2020 | 2472 | 0.080 |
Why?
|
Fibroadenoma | 1 | 2009 | 41 | 0.080 |
Why?
|
Pregnancy | 7 | 2024 | 29893 | 0.080 |
Why?
|
United States | 15 | 2021 | 72339 | 0.080 |
Why?
|
Mastectomy | 3 | 2022 | 1818 | 0.080 |
Why?
|
Mucins | 2 | 2022 | 569 | 0.080 |
Why?
|
Estrogen Receptor beta | 1 | 2009 | 169 | 0.080 |
Why?
|
Cyclooxygenase 2 | 1 | 2011 | 597 | 0.080 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2010 | 208 | 0.080 |
Why?
|
Receptor, IGF Type 1 | 1 | 2011 | 380 | 0.080 |
Why?
|
Bone Resorption | 1 | 2012 | 723 | 0.080 |
Why?
|
Observer Variation | 3 | 2021 | 2610 | 0.080 |
Why?
|
Cooperative Behavior | 2 | 2014 | 1506 | 0.080 |
Why?
|
Acetaminophen | 1 | 2012 | 555 | 0.080 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2011 | 410 | 0.080 |
Why?
|
Time Factors | 9 | 2013 | 39957 | 0.080 |
Why?
|
Endometriosis | 1 | 2016 | 870 | 0.080 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2022 | 899 | 0.070 |
Why?
|
Nuts | 1 | 2010 | 264 | 0.070 |
Why?
|
Heat-Shock Proteins | 1 | 2011 | 795 | 0.070 |
Why?
|
Cathepsins | 1 | 2008 | 241 | 0.070 |
Why?
|
Mastectomy, Simple | 1 | 2007 | 23 | 0.070 |
Why?
|
Basidiomycota | 1 | 2007 | 17 | 0.070 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2007 | 714 | 0.070 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2019 | 8530 | 0.070 |
Why?
|
Prostatic Neoplasms | 2 | 2007 | 11101 | 0.070 |
Why?
|
Seroma | 1 | 2007 | 73 | 0.070 |
Why?
|
Carcinoma, Large Cell | 1 | 2007 | 113 | 0.070 |
Why?
|
Heterozygote | 2 | 2012 | 2778 | 0.070 |
Why?
|
Chemokines, CXC | 1 | 2008 | 416 | 0.070 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 2006 | 68 | 0.070 |
Why?
|
Diet | 3 | 2014 | 8048 | 0.070 |
Why?
|
Exercise | 2 | 2015 | 5874 | 0.070 |
Why?
|
Keratin-14 | 1 | 2006 | 56 | 0.070 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 1 | 2006 | 88 | 0.070 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2006 | 146 | 0.070 |
Why?
|
Dietary Fiber | 1 | 2010 | 758 | 0.070 |
Why?
|
Interdisciplinary Communication | 1 | 2012 | 931 | 0.060 |
Why?
|
Codon, Nonsense | 1 | 2007 | 284 | 0.060 |
Why?
|
Multivariate Analysis | 6 | 2019 | 12052 | 0.060 |
Why?
|
Bile Canaliculi | 1 | 2005 | 11 | 0.060 |
Why?
|
Lysine | 3 | 2014 | 982 | 0.060 |
Why?
|
Osteogenesis | 1 | 2012 | 1273 | 0.060 |
Why?
|
Premenopause | 3 | 2020 | 1039 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2001 | 4021 | 0.060 |
Why?
|
Folic Acid | 1 | 2012 | 1323 | 0.060 |
Why?
|
Tumor Suppressor Proteins | 1 | 2015 | 2803 | 0.060 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2007 | 246 | 0.060 |
Why?
|
Tamoxifen | 2 | 2009 | 965 | 0.060 |
Why?
|
Transfection | 3 | 2001 | 5748 | 0.060 |
Why?
|
Managed Care Programs | 1 | 2010 | 937 | 0.060 |
Why?
|
Antineoplastic Agents, Hormonal | 3 | 2011 | 1520 | 0.060 |
Why?
|
Carcinoid Tumor | 1 | 2006 | 225 | 0.060 |
Why?
|
Psychometrics | 1 | 2014 | 3061 | 0.060 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2017 | 3366 | 0.060 |
Why?
|
Neuroanatomy | 2 | 2001 | 71 | 0.060 |
Why?
|
Muscle, Smooth, Vascular | 2 | 2001 | 1488 | 0.060 |
Why?
|
Patient-Centered Care | 1 | 2014 | 1427 | 0.060 |
Why?
|
Lymphatic Metastasis | 4 | 2019 | 2913 | 0.060 |
Why?
|
Neoplastic Processes | 1 | 2023 | 36 | 0.060 |
Why?
|
Histones | 1 | 2014 | 2570 | 0.060 |
Why?
|
Treatment Outcome | 8 | 2020 | 64681 | 0.060 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2023 | 2549 | 0.060 |
Why?
|
Retrospective Studies | 11 | 2024 | 80674 | 0.060 |
Why?
|
Pathology, Clinical | 2 | 2006 | 376 | 0.060 |
Why?
|
Polymerase Chain Reaction | 2 | 2010 | 6067 | 0.050 |
Why?
|
Neoplasm Proteins | 2 | 2013 | 3594 | 0.050 |
Why?
|
Caspases | 1 | 2006 | 878 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2012 | 10756 | 0.050 |
Why?
|
Tight Junctions | 1 | 2005 | 324 | 0.050 |
Why?
|
Quality of Life | 1 | 2024 | 13367 | 0.050 |
Why?
|
Early Detection of Cancer | 2 | 2014 | 3198 | 0.050 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 2270 | 0.050 |
Why?
|
Disease Progression | 2 | 2017 | 13511 | 0.050 |
Why?
|
STAT5 Transcription Factor | 1 | 2023 | 266 | 0.050 |
Why?
|
Dissection | 1 | 2024 | 297 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2006 | 726 | 0.050 |
Why?
|
Drug Synergism | 1 | 2006 | 1756 | 0.050 |
Why?
|
Cation Exchange Resins | 1 | 2001 | 19 | 0.050 |
Why?
|
Hemagglutinins, Viral | 1 | 2001 | 66 | 0.050 |
Why?
|
Terminology as Topic | 1 | 2009 | 1528 | 0.050 |
Why?
|
Family Health | 1 | 2006 | 1254 | 0.050 |
Why?
|
Antibodies, Bispecific | 1 | 2024 | 196 | 0.050 |
Why?
|
Hemagglutinins | 1 | 2001 | 111 | 0.050 |
Why?
|
Anatomy, Artistic | 1 | 2001 | 51 | 0.050 |
Why?
|
DNA Repair | 1 | 2010 | 2041 | 0.050 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2001 | 139 | 0.050 |
Why?
|
Stereotaxic Techniques | 1 | 2004 | 555 | 0.050 |
Why?
|
Cytodiagnosis | 1 | 2005 | 447 | 0.050 |
Why?
|
Patient Selection | 2 | 2012 | 4246 | 0.050 |
Why?
|
Medical Illustration | 1 | 2001 | 135 | 0.040 |
Why?
|
North America | 1 | 2024 | 1284 | 0.040 |
Why?
|
Carcinoma, Renal Cell | 1 | 2015 | 3163 | 0.040 |
Why?
|
Calcinosis | 1 | 2009 | 1477 | 0.040 |
Why?
|
Respiratory Muscles | 1 | 2001 | 142 | 0.040 |
Why?
|
Staining and Labeling | 1 | 2005 | 1080 | 0.040 |
Why?
|
Chloroquine | 1 | 2001 | 274 | 0.040 |
Why?
|
Carbonated Beverages | 1 | 2021 | 210 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2023 | 800 | 0.040 |
Why?
|
Neoplasms | 3 | 2024 | 22140 | 0.040 |
Why?
|
Monosomy | 1 | 1999 | 52 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2011 | 3493 | 0.040 |
Why?
|
Body Mass Index | 3 | 2021 | 12952 | 0.040 |
Why?
|
Immunoenzyme Techniques | 2 | 2015 | 1703 | 0.040 |
Why?
|
Genome-Wide Association Study | 1 | 2019 | 12676 | 0.040 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2022 | 355 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2014 | 4014 | 0.040 |
Why?
|
Carcinoma | 1 | 2010 | 2330 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 3 | 2019 | 6486 | 0.040 |
Why?
|
Quality of Health Care | 1 | 2014 | 4320 | 0.040 |
Why?
|
Reflex | 1 | 2001 | 374 | 0.040 |
Why?
|
Kidney Neoplasms | 1 | 2015 | 4251 | 0.040 |
Why?
|
Germ-Line Mutation | 1 | 2007 | 1852 | 0.040 |
Why?
|
Calcium | 1 | 2012 | 5719 | 0.040 |
Why?
|
Sweetening Agents | 1 | 2021 | 290 | 0.040 |
Why?
|
Patient Compliance | 1 | 2009 | 2688 | 0.040 |
Why?
|
Elasticity | 1 | 2021 | 655 | 0.040 |
Why?
|
Peptides | 2 | 2001 | 4353 | 0.040 |
Why?
|
Germ Cells | 1 | 2022 | 632 | 0.040 |
Why?
|
Women's Health | 1 | 2008 | 2070 | 0.040 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 1999 | 534 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2016 | 3777 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2015 | 7400 | 0.040 |
Why?
|
Sex Reassignment Surgery | 1 | 2020 | 164 | 0.040 |
Why?
|
DNA | 2 | 2022 | 7189 | 0.040 |
Why?
|
Algorithms | 2 | 2016 | 14025 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2004 | 14675 | 0.030 |
Why?
|
Organoids | 1 | 2023 | 744 | 0.030 |
Why?
|
Respiratory Mechanics | 1 | 2001 | 698 | 0.030 |
Why?
|
Retinoid X Receptors | 1 | 2016 | 91 | 0.030 |
Why?
|
Animals | 9 | 2017 | 168079 | 0.030 |
Why?
|
Cell Polarity | 1 | 2020 | 638 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2011 | 3512 | 0.030 |
Why?
|
Huntington Disease | 1 | 2003 | 1145 | 0.030 |
Why?
|
Cold Temperature | 1 | 2000 | 783 | 0.030 |
Why?
|
Automation, Laboratory | 1 | 2016 | 102 | 0.030 |
Why?
|
Anthropometry | 1 | 2020 | 1338 | 0.030 |
Why?
|
Beverages | 1 | 2021 | 821 | 0.030 |
Why?
|
Ultrasonography | 1 | 2009 | 5969 | 0.030 |
Why?
|
Prenatal Diagnosis | 1 | 2003 | 1267 | 0.030 |
Why?
|
Databases, Factual | 2 | 2001 | 7966 | 0.030 |
Why?
|
Radioimmunoassay | 1 | 2016 | 862 | 0.030 |
Why?
|
Neoplasm Metastasis | 2 | 2024 | 4909 | 0.030 |
Why?
|
Tumor Microenvironment | 2 | 2023 | 3873 | 0.030 |
Why?
|
Oncogene Protein v-akt | 1 | 2015 | 129 | 0.030 |
Why?
|
Transcription Factors | 1 | 2015 | 12099 | 0.030 |
Why?
|
Colposcopy | 1 | 1996 | 149 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2012 | 10422 | 0.030 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2015 | 164 | 0.030 |
Why?
|
Lymph Nodes | 2 | 2019 | 3461 | 0.030 |
Why?
|
Genetic Variation | 1 | 2010 | 6567 | 0.030 |
Why?
|
Case Management | 1 | 1996 | 272 | 0.030 |
Why?
|
Population Surveillance | 2 | 2015 | 2598 | 0.030 |
Why?
|
Viral Proteins | 1 | 2001 | 1798 | 0.030 |
Why?
|
Multiple Myeloma | 1 | 2012 | 5145 | 0.030 |
Why?
|
Nursing Staff | 1 | 2015 | 113 | 0.030 |
Why?
|
Europe | 1 | 2021 | 3423 | 0.030 |
Why?
|
Receptors, Calcitriol | 1 | 2016 | 360 | 0.030 |
Why?
|
Thienamycins | 1 | 1993 | 29 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 1999 | 2509 | 0.030 |
Why?
|
Registries | 1 | 2009 | 8247 | 0.030 |
Why?
|
Ontario | 1 | 2014 | 398 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2022 | 2024 | 0.030 |
Why?
|
Lipid Metabolism | 1 | 2001 | 1893 | 0.030 |
Why?
|
RNA, Messenger | 3 | 2013 | 12747 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2007 | 16952 | 0.030 |
Why?
|
Fibroblasts | 1 | 2023 | 4137 | 0.030 |
Why?
|
Male | 11 | 2024 | 360693 | 0.030 |
Why?
|
Menopause | 1 | 2021 | 1646 | 0.030 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2009 | 1784 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 2020 | 8519 | 0.030 |
Why?
|
Gram-Positive Bacteria | 1 | 1993 | 176 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2021 | 6223 | 0.020 |
Why?
|
Peptide Fragments | 2 | 2001 | 5103 | 0.020 |
Why?
|
Liver | 2 | 2005 | 7514 | 0.020 |
Why?
|
Epoxy Compounds | 1 | 2012 | 137 | 0.020 |
Why?
|
Gram-Negative Bacteria | 1 | 1993 | 271 | 0.020 |
Why?
|
Methylation | 1 | 2014 | 1070 | 0.020 |
Why?
|
Survival Rate | 2 | 2020 | 12728 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2022 | 2636 | 0.020 |
Why?
|
Calcification, Physiologic | 1 | 2012 | 170 | 0.020 |
Why?
|
Micronutrients | 1 | 2014 | 381 | 0.020 |
Why?
|
Students, Nursing | 1 | 2012 | 45 | 0.020 |
Why?
|
Receptor, Insulin | 1 | 2015 | 836 | 0.020 |
Why?
|
Therapeutic Irrigation | 2 | 2005 | 293 | 0.020 |
Why?
|
Prevalence | 1 | 2008 | 15721 | 0.020 |
Why?
|
Nurse Practitioners | 1 | 2014 | 269 | 0.020 |
Why?
|
Epidemiologic Studies | 1 | 2014 | 677 | 0.020 |
Why?
|
Nursing Staff, Hospital | 1 | 2014 | 348 | 0.020 |
Why?
|
Graft Rejection | 2 | 2001 | 4481 | 0.020 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2012 | 426 | 0.020 |
Why?
|
HCT116 Cells | 1 | 2011 | 405 | 0.020 |
Why?
|
Nutritional Requirements | 1 | 2012 | 274 | 0.020 |
Why?
|
Allied Health Personnel | 1 | 2012 | 154 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2023 | 4574 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2016 | 1741 | 0.020 |
Why?
|
Thrombin | 1 | 1992 | 593 | 0.020 |
Why?
|
Pyrroles | 1 | 2015 | 1124 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2021 | 3313 | 0.020 |
Why?
|
Medical Audit | 1 | 2010 | 452 | 0.020 |
Why?
|
Cathepsin K | 1 | 2008 | 64 | 0.020 |
Why?
|
ROC Curve | 1 | 2016 | 3584 | 0.020 |
Why?
|
Osteoclasts | 1 | 2012 | 711 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2001 | 4935 | 0.020 |
Why?
|
Self Report | 1 | 2020 | 3727 | 0.020 |
Why?
|
Necrosis | 1 | 2012 | 1610 | 0.020 |
Why?
|
Boronic Acids | 1 | 2012 | 915 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2013 | 1118 | 0.020 |
Why?
|
Program Development | 1 | 2014 | 1294 | 0.020 |
Why?
|
Alleles | 1 | 2019 | 6857 | 0.020 |
Why?
|
Rabbits | 3 | 2001 | 4750 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2012 | 1822 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2011 | 1535 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2010 | 748 | 0.020 |
Why?
|
Genes, Reporter | 2 | 2001 | 1518 | 0.020 |
Why?
|
Age Distribution | 1 | 2013 | 2871 | 0.020 |
Why?
|
Indoles | 1 | 2015 | 1830 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 4 | 2009 | 36415 | 0.020 |
Why?
|
Caspase 2 | 1 | 2007 | 26 | 0.020 |
Why?
|
Personal Satisfaction | 1 | 2012 | 645 | 0.020 |
Why?
|
Urinary Bladder Neoplasms | 1 | 1999 | 2223 | 0.020 |
Why?
|
Mice, SCID | 1 | 2012 | 2621 | 0.020 |
Why?
|
SEER Program | 1 | 2012 | 1453 | 0.020 |
Why?
|
Estrogen Replacement Therapy | 1 | 2013 | 1208 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2014 | 1265 | 0.020 |
Why?
|
Osteoblasts | 1 | 2012 | 1144 | 0.020 |
Why?
|
Dietary Fats | 1 | 2014 | 1994 | 0.020 |
Why?
|
Caspase 8 | 1 | 2007 | 190 | 0.020 |
Why?
|
Pyrazines | 1 | 2012 | 1202 | 0.020 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2024 | 4575 | 0.020 |
Why?
|
Heart Transplantation | 1 | 2000 | 3258 | 0.020 |
Why?
|
Cytoplasm | 1 | 2011 | 1498 | 0.020 |
Why?
|
Brain Mapping | 1 | 2001 | 6635 | 0.020 |
Why?
|
California | 1 | 2010 | 1431 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2019 | 15920 | 0.020 |
Why?
|
Interprofessional Relations | 1 | 2012 | 990 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2012 | 2706 | 0.020 |
Why?
|
Egtazic Acid | 1 | 2005 | 166 | 0.020 |
Why?
|
Models, Molecular | 1 | 2015 | 5406 | 0.020 |
Why?
|
Fibrosis | 1 | 2012 | 2051 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2015 | 6819 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2011 | 1186 | 0.020 |
Why?
|
Infusions, Parenteral | 1 | 2005 | 398 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 4567 | 0.020 |
Why?
|
Loss of Heterozygosity | 1 | 2007 | 662 | 0.020 |
Why?
|
Antigens, CD | 1 | 2015 | 4009 | 0.020 |
Why?
|
Mass Screening | 1 | 2001 | 5426 | 0.020 |
Why?
|
Motor Activity | 1 | 2015 | 2712 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2021 | 14610 | 0.020 |
Why?
|
DNA Methylation | 2 | 2010 | 4384 | 0.010 |
Why?
|
Blotting, Western | 1 | 2012 | 5032 | 0.010 |
Why?
|
Laparoscopy | 1 | 2016 | 2035 | 0.010 |
Why?
|
Caspase 3 | 1 | 2007 | 730 | 0.010 |
Why?
|
Genotype | 1 | 2019 | 12985 | 0.010 |
Why?
|
Brain | 2 | 2001 | 27092 | 0.010 |
Why?
|
Body Weight | 1 | 2015 | 4618 | 0.010 |
Why?
|
Administration, Oral | 1 | 2012 | 4015 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2011 | 1662 | 0.010 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2012 | 940 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2001 | 7851 | 0.010 |
Why?
|
Genetic Heterogeneity | 1 | 2007 | 734 | 0.010 |
Why?
|
Chelating Agents | 1 | 2005 | 383 | 0.010 |
Why?
|
Rats, Inbred Lew | 1 | 2005 | 1159 | 0.010 |
Why?
|
Haplotypes | 1 | 2010 | 2715 | 0.010 |
Why?
|
Permeability | 1 | 2005 | 721 | 0.010 |
Why?
|
Thrombolytic Therapy | 1 | 1992 | 2055 | 0.010 |
Why?
|
Life Style | 1 | 2014 | 3907 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2000 | 9566 | 0.010 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2007 | 732 | 0.010 |
Why?
|
Rats | 3 | 2005 | 23704 | 0.010 |
Why?
|
Lung | 1 | 2001 | 9979 | 0.010 |
Why?
|
Learning | 1 | 2012 | 1737 | 0.010 |
Why?
|
Crotalus | 1 | 2001 | 7 | 0.010 |
Why?
|
Bone Marrow | 1 | 2012 | 2911 | 0.010 |
Why?
|
Genes, BRCA2 | 1 | 2005 | 591 | 0.010 |
Why?
|
Drug Administration Routes | 1 | 2001 | 150 | 0.010 |
Why?
|
Trinucleotide Repeat Expansion | 1 | 2003 | 247 | 0.010 |
Why?
|
Gold | 1 | 2005 | 482 | 0.010 |
Why?
|
Cell Membrane | 1 | 2011 | 3661 | 0.010 |
Why?
|
Factor IX | 1 | 2001 | 76 | 0.010 |
Why?
|
Blood Platelets | 1 | 1992 | 2477 | 0.010 |
Why?
|
Lac Operon | 1 | 2001 | 237 | 0.010 |
Why?
|
Particle Size | 1 | 2005 | 1649 | 0.010 |
Why?
|
Phrenic Nerve | 1 | 2001 | 79 | 0.010 |
Why?
|
Inhalation | 1 | 2001 | 143 | 0.010 |
Why?
|
Health Personnel | 1 | 2014 | 3337 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 2001 | 2087 | 0.010 |
Why?
|
Saline Solution, Hypertonic | 1 | 2001 | 114 | 0.010 |
Why?
|
Bile Ducts | 1 | 2001 | 284 | 0.010 |
Why?
|
Child | 2 | 2020 | 80152 | 0.010 |
Why?
|
Regression Analysis | 1 | 2010 | 6345 | 0.010 |
Why?
|
Binding, Competitive | 1 | 2001 | 1140 | 0.010 |
Why?
|
Nanostructures | 1 | 2005 | 551 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2010 | 2915 | 0.010 |
Why?
|
Abdominal Muscles | 1 | 2001 | 169 | 0.010 |
Why?
|
beta-Galactosidase | 1 | 2001 | 574 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2012 | 26071 | 0.010 |
Why?
|
Catheterization | 1 | 2005 | 1428 | 0.010 |
Why?
|
Pedigree | 1 | 2007 | 4537 | 0.010 |
Why?
|
Cell Line | 2 | 2005 | 15545 | 0.010 |
Why?
|
Luciferases | 1 | 2001 | 710 | 0.010 |
Why?
|
Amino Acid Motifs | 1 | 2001 | 924 | 0.010 |
Why?
|
Portal Vein | 1 | 2001 | 432 | 0.010 |
Why?
|
Survival Analysis | 1 | 2011 | 10088 | 0.010 |
Why?
|
Vagus Nerve | 1 | 2001 | 458 | 0.010 |
Why?
|
Recurrence | 1 | 2010 | 8457 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2012 | 3885 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 42224 | 0.010 |
Why?
|
Up-Regulation | 1 | 2007 | 4111 | 0.010 |
Why?
|
Canada | 1 | 2003 | 2125 | 0.010 |
Why?
|
Communication | 1 | 2012 | 3872 | 0.010 |
Why?
|
Hydrogen Peroxide | 1 | 2001 | 731 | 0.010 |
Why?
|
Massachusetts | 1 | 2010 | 8837 | 0.010 |
Why?
|
Stomach Neoplasms | 1 | 2007 | 1457 | 0.010 |
Why?
|
Age of Onset | 1 | 2003 | 3307 | 0.010 |
Why?
|
Axilla | 1 | 1998 | 624 | 0.010 |
Why?
|
Probability | 1 | 2001 | 2478 | 0.010 |
Why?
|
Chronic Disease | 2 | 2001 | 9319 | 0.010 |
Why?
|
Electromyography | 1 | 2001 | 1393 | 0.010 |
Why?
|
Research Design | 1 | 2011 | 6180 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2012 | 11509 | 0.010 |
Why?
|
Ligands | 1 | 2001 | 3264 | 0.010 |
Why?
|
Imipenem | 1 | 1993 | 37 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2012 | 22127 | 0.010 |
Why?
|
Binding Sites | 1 | 2001 | 5988 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2001 | 6199 | 0.010 |
Why?
|
Methicillin Resistance | 1 | 1993 | 198 | 0.010 |
Why?
|
Obesity | 1 | 2015 | 12939 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2001 | 4822 | 0.010 |
Why?
|
Pilot Projects | 1 | 2005 | 8642 | 0.010 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 1993 | 237 | 0.010 |
Why?
|
Hirudins | 1 | 1992 | 179 | 0.010 |
Why?
|
Mice | 2 | 2012 | 81326 | 0.010 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 1993 | 342 | 0.010 |
Why?
|
Image Enhancement | 1 | 2001 | 2888 | 0.010 |
Why?
|
Lipids | 1 | 2001 | 3331 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2001 | 13402 | 0.010 |
Why?
|
Respiration, Artificial | 1 | 2001 | 2631 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2001 | 17598 | 0.000 |
Why?
|
Platelet Aggregation | 1 | 1992 | 771 | 0.000 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2001 | 2293 | 0.000 |
Why?
|
Platelet Activation | 1 | 1992 | 646 | 0.000 |
Why?
|
Imaging, Three-Dimensional | 1 | 2001 | 4052 | 0.000 |
Why?
|
Microbial Sensitivity Tests | 1 | 1993 | 1936 | 0.000 |
Why?
|
Models, Statistical | 1 | 2001 | 5081 | 0.000 |
Why?
|
Tissue Plasminogen Activator | 1 | 1992 | 1162 | 0.000 |
Why?
|
Heparin | 1 | 1992 | 1632 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 2006 | 20588 | 0.000 |
Why?
|
Schizophrenia | 1 | 2001 | 6930 | 0.000 |
Why?
|
Anti-Bacterial Agents | 1 | 1993 | 7407 | 0.000 |
Why?
|